Nyxoah SA (NYXH) Form 6-K — Jun 23, 2026
Nyxoah SA received $15.0 million (€13.8 million) from the second tranche of its loan facility with the European Investment Bank. This non-dilutive funding brings the total new capital raised by the company in June 2026 to approximately $110 million, combining recent equity proceeds with the EIB financing. Proceeds from the EIB loan are designated to accelerate the commercial launch of the Genio system in the United States, as well as support ongoing research and development and manufacturing scale-up. The funding strengthens the company's balance sheet without diluting existing shareholders.
Key figures
- Debt Amount
- 15000000
- Total shares denominator
- 99926284
- Robert taub stake percent
- 14.45%
- Total capital raised june usd
- 110000000
- Cochlear limited stake percent
- 5.85%
- Pierre edouard sterin stake percent
- 7.23%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.